Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
What are the key steps to effective delivery of PrEP care?

Providing pre-exposure prophylaxis (PrEP) to people who need it entails at least nine key steps, which can be conceived of as a PrEP continuum of care,

Published
1 hour ago
By
Roger Pebody
Press Ban at National PrEP Summit Was a Bad Idea for HIV Community

The National Minority AIDS Council banned press from its National PrEP Summit in December. At a time when we need more press focus on HIV prevention methods and the systemic barriers preventing those methods from getting the people who need them most, NMAC's decision is the wrong one.

Published
18 January 2017
From
The Body
New HIV prevention treatment can only work if perception improves

A De Montfort University Leicester (DMU) professor and his PhD student have urged the medical profession and media to change the way in which a new HIV prevention treatment is represented if they want it to work. He found that men who would benefit most from taking PrEP were being put off by its association with “high risk” people – as they did not want to place themselves in this category.

Published
18 January 2017
From
De Montfort University (press release)
PrEP HIV prevention drug trial expanded in Victoria but fears people still missing out

The Victorian AIDS Council (VAC) said 2,600 places in the Victorian trial were exhausted within about six months of opening last July. The organisation funded the trial along with the State Government and Alfred Health and this week allocated another $100,000 to allow a further 600 people to take part. But the existing waiting list already has about 550 people on it, and the Federal Government has been urged to support greater access to the drug across Australia.

Published
18 January 2017
From
ABC Online
Successful antibody trial in HIV-infected individuals

A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research, has tested a new HIV neutralizing antibody, called 10-1074, in humans. The results of the trial have just been published in Nature Medicine.

Published
17 January 2017
From
Eurekalert Inf Dis
PrEP: A Dream Deferred

PrEP is largely failing to help those who need an HIV prevention game changer most desperately, namely Black MSM, in particular those younger than 25.

Published
17 January 2017
From
Poz
Zimbabwe: Zim to Roll Out Pre-Exposure HIV Pill

ZIMBABWE will soon start rolling out pre-exposure prophylaxis (PrEP) medication in selected districts in the country after adopting World Health Organisation (WHO) guidelines on HIV treatment and prevention.

Published
16 January 2017
From
AllAfrica
People taking ART in the UK have an accurate understanding of their viral load

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report

Published
16 January 2017
By
Michael Carter
HIV diagnoses falling steeply, early figures show: London clinics see hope in increased use of pre-exposure prophylaxis

Early figures from four London sexual health clinics reveal a steep decline in the rate of HIV diagnoses in 2016, raising the possibility that the virus could be managed out of existence in the UK. The fall might be explained by the increased use of medicines called pre-exposure prophylaxis, or PrEP. The medicines are provided by the clinics but are also for sale online, though they are not available on the NHS.

Published
13 January 2017
From
Financial Times
Implants and injectables: PrEP in the future

Last month’s announcement that the Bill and Melinda Gates Foundation will give up to $140 million to a Boston drug device manufacturer to develop an

Published
13 January 2017
By
Keith Alcorn
← First12345...514Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.